Frias Jaime A. 4
4 · TREACE MEDICAL CONCEPTS, INC. · Filed Apr 29, 2021
Insider Transaction Report
Form 4
Frias Jaime A.
See Remarks
Transactions
- Conversion
Common Stock
2021-04-27+85,570→ 225,551 total(indirect: By Trust) - Other
Series A Preferred Stock
2021-04-27+1,976→ 85,570 total(indirect: By Trust)→ Common Stock (1,976 underlying) - Conversion
Common Stock
2021-04-27+42,785→ 372,016 total - Conversion
Series A Preferred Stock
2021-04-27−42,785→ 0 total→ Common Stock (42,785 underlying) - Sale
Common Stock
2021-04-27$17.00/sh−329,230$5,596,910→ 42,786 total - Other
Series A Preferred Stock
2021-04-27+988→ 42,785 total→ Common Stock (988 underlying) - Conversion
Series A Preferred Stock
2021-04-27−85,570→ 0 total(indirect: By Trust)→ Common Stock (85,570 underlying)
Footnotes (3)
- [F1]Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The Shares had no expiration date.
- [F2]These shares were sold by the Reporting Person as a selling stockholder in conjuction with the Issuer's Form S-1 filing, Registration Number 333-254863. The offering closed on April 27, 2021. The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters.
- [F3]The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.